Berlin – A new report from the Peterson Health Technology Institute (PHTI) suggests that virtual gastrointestinal (GI) solutions are not only improving symptoms for patients suffering from debilitating conditions like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), but are also demonstrably lowering healthcare costs. The findings, released this month, offer a compelling case for the wider adoption of telehealth in gastroenterology, a field often plagued by long wait times and complex care pathways.
The increasing prevalence of GI disorders – affecting approximately one in five adults in the United States – coupled with the substantial financial burden they place on the healthcare system (estimated at $112 billion annually) has spurred a search for more effective and affordable treatment options. Traditional gastroenterological care can be fragmented and difficult to access, leading to delayed diagnoses and suboptimal management of chronic conditions. Virtual GI solutions, encompassing a range of digital tools and services, are emerging as a potential solution to these challenges.
PHTI, an independent evaluator of digital health solutions, undertook a comprehensive assessment of the clinical and economic impact of these virtual care models. The evaluation, conducted in collaboration with clinical advisors and experts in gastroenterology, health economics, and health technology assessment, analyzed two primary categories of virtual GI solutions: “wraparound” programs and “clinician-led” programs. The report’s findings are particularly noteworthy given the current landscape of digital health, where demonstrable cost savings have often been elusive.
Understanding the Two Approaches to Virtual GI Care
The PHTI report categorizes virtual GI solutions into two distinct models. Wraparound solutions are designed to complement existing GI care, offering additional support in areas such as nutrition counseling, gut-brain behavioral health, and symptom tracking. Companies like Cylinder Health and Digbi Health fall into this category. These programs typically aim to empower patients to actively manage their conditions through lifestyle modifications and self-monitoring. Clinician-led solutions, integrate gastroenterologists with other healthcare professionals and support services to provide a more comprehensive, multidisciplinary approach to care. Ayble Health, Oshi Health, and Salvo Health are examples of companies offering this type of service.
The key difference lies in the level of direct physician involvement. Wraparound solutions often operate as adjuncts to traditional care, while clinician-led solutions aim to provide a more complete virtual care experience, often substituting for some in-person visits.
Cost Savings and Symptom Improvement: The Findings
The PHTI analysis revealed significant benefits associated with both types of virtual GI solutions, although the impact varied depending on the specific condition. For patients with irritable bowel syndrome (IBS), wraparound solutions demonstrated improvements in symptoms and quality of life compared to usual care, and crucially, resulted in a decrease in net healthcare spending of $1,889 per year per patient in the commercial market. This represents a substantial cost reduction, particularly when considering the chronic nature of IBS and the often-limited effectiveness of traditional treatments.
While wraparound solutions did not demonstrate a statistically significant impact on IBD symptoms in the study, clinician-led solutions did demonstrate improvements in both symptoms and quality of life for patients with IBS and/or IBD. These programs also yielded average cost savings of $2,901 per user, making them a potentially attractive option for both patients and payers. Caroline Pearson, executive director of the Peterson Health Technology Institute, highlighted the significance of these findings, stating, “For the first time, we’re seeing real healthcare savings in the thousands of dollars per engaged patient, compared with savings in the hundreds for categories we previously evaluated, such as digital hypertension or musculoskeletal care.”
Implications for Patients, Payers, and Policymakers
The PHTI report has far-reaching implications for various stakeholders in the healthcare ecosystem. For purchasers of healthcare – including employers and insurance companies – the evidence supports the broader adoption of virtual GI solutions as a means of improving patient outcomes and controlling costs. However, Pearson cautions that a careful balance must be struck between patient needs, access to specialist care, and the cost of different programs. Lower-cost wraparound programs may be suitable for patients with IBS, while higher-priced clinician-led options may be more appropriate for those with IBD or more complex cases.
Policymakers also have a role to play in fostering the growth of virtual care. The findings underscore the potential for telehealth to address access gaps and improve healthcare delivery, particularly in underserved areas. Expanding insurance coverage for virtual GI solutions and streamlining regulatory requirements could accelerate their adoption. For digital health companies, the report sends a clear message: evidence matters. Companies that invest in rigorous research and demonstrate sustained clinical and economic benefits will be best positioned to succeed in the increasingly competitive digital health market. Pearson emphasized that “Companies that invest in stronger evidence — and align pricing with sustained outcomes rather than short-term engagement — will be far better positioned in the market.”
The Need for Long-Term Data
Despite the promising results, the PHTI report acknowledges the need for further research. The available studies often have short follow-up periods, limiting our understanding of the long-term effects of virtual GI solutions. There is a lack of data on performance across diverse populations and the effectiveness of these programs at different stages of disease. More robust research is needed to address these gaps and ensure that virtual GI solutions are equitable and effective for all patients.
The challenges of long wait times for gastroenterology appointments are well-documented. According to a 2023 report by Epic Health Research Network, the average wait time to spot a gastroenterologist is 32 days, significantly longer than for many other specialties. Epic Health Research Network This delay in access to care can exacerbate symptoms and lead to poorer outcomes for patients with GI disorders.
Looking Ahead: The Future of Virtual GI Care
The PHTI report represents a significant step forward in our understanding of the potential of virtual GI solutions. As technology continues to evolve and more data becomes available, these programs are likely to become even more sophisticated and effective. The integration of artificial intelligence (AI) and machine learning (ML) could personalize treatment plans and predict symptom flares, while remote monitoring devices could provide real-time insights into patient health. The future of gastroenterology is likely to be a hybrid model, combining the best of in-person care with the convenience and accessibility of virtual solutions.
The ongoing evaluation of digital health interventions by organizations like PHTI is crucial for ensuring that these technologies are deployed responsibly and effectively. By prioritizing evidence-based approaches and focusing on patient outcomes, One can harness the power of digital health to transform the care of GI disorders and improve the lives of millions of people.
The Peterson Health Technology Institute will continue to monitor the evolving landscape of virtual GI care and publish further assessments as new data becomes available. Interested parties can identify more information about PHTI’s work and access the full report on their website: https://phti.org/
What are your thoughts on the role of virtual care in gastroenterology? Share your experiences and opinions in the comments below. And please share this article with your network to help raise awareness about the potential of these innovative solutions.